CD47-targeting monoclonal antibody
This page covers all CD47-targeting monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD47.
Targets
Phase 2 pipeline (1)
- BIIB091 · Biogen · Oncology
BIIB091 is a monoclonal antibody targeting CD47.
Patent intelligence
- cd47 targeting monoclonal antibody patent landscape — aggregated cliff calendar, attackable patents, originator estates